Tumor suppressor activity of RIG-I

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Retinoic acid inducible gene-I (RIG-I) is a pattern recognition receptor (PRR) crucial for innate immunity against viral RNA.
• RIG-I activation leads to downstream signaling via IPS-1 (MAVS/VISA/Cardif), activating IRF3/7 and NF-κB pathways for type I interferon production.

Purpose of the Study:

• To review recent findings on RIG-I's non-immune roles.
• To highlight RIG-I's function as a tumor suppressor.
• To reconcile RIG-I's tumor suppressor activity with its antiviral functions.

Main Methods:

• Literature review of recent studies on RIG-I.
• Analysis of RIG-I's involvement in cellular processes beyond viral recognition.
• Synthesis of evidence for RIG-I's tumor suppressor role.

Main Results:

• RIG-I is implicated in regulating hematopoietic proliferation and differentiation.
• RIG-I plays a role in maintaining leukemic stemness and hepatocellular carcinoma tumorigenesis.
• Evidence suggests RIG-I functions as a tumor suppressor.

Conclusions:

• RIG-I has critical roles in cellular processes independent of viral immunity.
• RIG-I acts as a tumor suppressor, impacting cancer development.
• Further research is needed to fully understand RIG-I's dual role in immunity and cancer.